Gastrointestinal Therapeutics Market: IBD/GERD Biologics & PPI...

added blog Other

2026-05-20 09:56:45 -

Gastrointestinal Therapeutics Market: IBD/GERD Biologics & PPI Drug Trends

" Exactitude Consultancy That Adds Flavour To Your Success" Gastrointestinal Therapeutics Market: Drug class trends for IBD, GERD, and IBS disease management and biological therapies. The global Gastrointestinal Therapeutics Market is projected to reach USD 44.50 Billion in 2026 and USD 68.40 Billion by 2033, growing at a 6.3% CAGR. If you're looking for insights into the...

0 Comments 0 Shares 469 Views 0 Reviews